Morgan Keegan is out with its report today on HMS Holdings HMSY, lowering its PT from $78 to $75.
In a note to clients, Morgan Keegan writes, "Our 12 month PT of $75 on shares of HMS is based on the assumption that the company achieves a multiple of 34x our
next twelve month estimate of $2.21 that excludes acquisition related intangible asset amortization and stock option expense. Assuming the S&P 500 appreciates 10% in the next 12 months, consensus estimates suggest it would be trading at a PEG ratio of 1.57x calendar 2011 estimates. We derived our 34x valuation for shares of HMSY by giving the company a PEG ratio that is in line with the S&P 500 on our estimated 21% EPS growth rate from 2011-14. Our prior PT was $78."
Morgan Keegan maintains Market Perform on HMSY.
Shares of HMSY closed Friday at $78.71.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareHealth Care ServicesHMS HoldingsMorgan Keegan
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in